🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates a personalized treatment strategy for patients with la...
Status
Not Yet Recruiting
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Start Date
2026-05-14
Trial ID
NCT07602322
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and tolerability ...
Status
Recruiting
Location
Liverpool Cancer Therapy Centre
Start Date
2025-11
Trial ID
NCT07244705
Treatments Being Tested
This is a Phase II clinical trial for Decitabine plus Camrelizumab resistan...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-02-02
Trial ID
NCT04233294
Treatments Being Tested
To observe the safety, tolerability and clinical effects of PD-1, chidamide...
Status
Unknown
Location
Oncology Department of The First Affilliated Hospital of Zhengzhou University
Start Date
2019-09-01
Trial ID
NCT04040491
Treatments Being Tested
This open-label, randomized, two-arm, phase 2 study has the primary objecti...
Status
Unknown
Location
Biotherapeutic Department of Chinese PLA General Hospital
Start Date
2020-08-01
Trial ID
NCT04514081
Treatments Being Tested
This is a study to assess the safety and efficacy of CXD101 in combination ...
Status
Unknown
Location
Celleron Therapeutics Ltd
Start Date
2018-05-22
Trial ID
NCT03993626
Treatments Being Tested
This phase Ib trial studies the side effects and best dose of entinostat wh...
Status
Completed
Location
Smilow Cancer Center/Yale-New Haven Hospital
Start Date
2017-06-23
Trial ID
NCT02936752
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of en...
Status
Completed
Location
Yale University
Start Date
2015-08-26
Trial ID
NCT02437136
Treatments Being Tested
The purpose of this study is to determine the biologically active dose of e...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research
Start Date
2016-12-19
Trial ID
NCT02915523
Treatments Being Tested
The purpose of this research study is to find the dose of the study drug PD...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-09
Trial ID
NCT03982134
Treatments Being Tested